Nang Kuang Pharmaceutical Co Ltd
Nang Kuang Pharmaceutical Co., Ltd. manufactures, processes, trades in, imports, and exports pharmaceuticals and medical devices in Taiwan, China, Japan, the United States, and internationally. The company offers ready to use injections, such as prefilled syringe injections and premixed IV infusions; anti-aging and preventive medicines; chemotherapy and oncology products; and non-PVC IV infusion.… Read more
Nang Kuang Pharmaceutical Co Ltd (1752) - Total Liabilities
Latest total liabilities as of December 2025: NT$1.33 Billion TWD
Based on the latest financial reports, Nang Kuang Pharmaceutical Co Ltd (1752) has total liabilities worth NT$1.33 Billion TWD as of December 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Nang Kuang Pharmaceutical Co Ltd - Total Liabilities Trend (2009–2025)
This chart illustrates how Nang Kuang Pharmaceutical Co Ltd's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Nang Kuang Pharmaceutical Co Ltd Competitors by Total Liabilities
The table below lists competitors of Nang Kuang Pharmaceutical Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Hi-Lai Foods Co Ltd
TWO:1268
|
Taiwan | NT$4.79 Billion |
|
Duksung Co Ltd
KO:004835
|
Korea | ₩64.30 Billion |
|
Lotte Chemical Titan Holding BHD
KLSE:5284
|
Malaysia | RM12.82 Billion |
|
Datalex
IR:DLE
|
Ireland | €18.15 Million |
|
Noble Development Public Company Limited
BK:NOBLE
|
Thailand | ฿18.06 Billion |
|
Eisen- und Hüttenwerke AG
F:EIS
|
Germany | €3.65 Million |
|
GD Express Carrier Bhd
KLSE:0078
|
Malaysia | RM167.34 Million |
|
Bank Nationalnobu Tbk
JK:NOBU
|
Indonesia | Rp33.65 Trillion |
Liability Composition Analysis (2009–2025)
This chart breaks down Nang Kuang Pharmaceutical Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.40 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.54 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.35 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Nang Kuang Pharmaceutical Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Nang Kuang Pharmaceutical Co Ltd (2009–2025)
The table below shows the annual total liabilities of Nang Kuang Pharmaceutical Co Ltd from 2009 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | NT$1.33 Billion | -4.11% |
| 2024-12-31 | NT$1.39 Billion | -5.96% |
| 2023-12-31 | NT$1.48 Billion | +26.04% |
| 2022-12-31 | NT$1.17 Billion | -1.28% |
| 2021-12-31 | NT$1.19 Billion | +12.61% |
| 2020-12-31 | NT$1.06 Billion | -4.05% |
| 2019-12-31 | NT$1.10 Billion | +12.88% |
| 2018-12-31 | NT$974.64 Million | -18.17% |
| 2017-12-31 | NT$1.19 Billion | +13.54% |
| 2016-12-31 | NT$1.05 Billion | -0.20% |
| 2015-12-31 | NT$1.05 Billion | -20.02% |
| 2014-12-31 | NT$1.31 Billion | +11.27% |
| 2013-12-31 | NT$1.18 Billion | -20.62% |
| 2012-12-31 | NT$1.49 Billion | +15.26% |
| 2011-12-31 | NT$1.29 Billion | +23.14% |
| 2010-12-31 | NT$1.05 Billion | +17.63% |
| 2009-12-31 | NT$891.18 Million | -- |